Aberdeen Group’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $502K | Sell |
14,148
-638
| -4% | -$22.6K | ﹤0.01% | 883 |
|
2025
Q1 | $502K | Sell |
14,786
-16,732
| -53% | -$568K | ﹤0.01% | 872 |
|
2024
Q4 | $1.03M | Sell |
31,518
-2,211
| -7% | -$72.1K | ﹤0.01% | 821 |
|
2024
Q3 | $1.63M | Buy |
33,729
+17,696
| +110% | +$854K | ﹤0.01% | 770 |
|
2024
Q2 | $710K | Buy |
16,033
+2,464
| +18% | +$109K | ﹤0.01% | 837 |
|
2024
Q1 | $761K | Sell |
13,569
-2,132
| -14% | -$120K | ﹤0.01% | 842 |
|
2023
Q4 | $945K | Buy |
15,701
+2,441
| +18% | +$147K | ﹤0.01% | 841 |
|
2023
Q3 | $891K | Sell |
13,260
-2,343
| -15% | -$157K | ﹤0.01% | 769 |
|
2023
Q2 | $1.08M | Buy |
15,603
+2,702
| +21% | +$187K | ﹤0.01% | 787 |
|
2023
Q1 | $622K | Sell |
12,901
-664
| -5% | -$32K | ﹤0.01% | 823 |
|
2022
Q4 | $677K | Buy |
13,565
+3,990
| +42% | +$199K | ﹤0.01% | 809 |
|
2022
Q3 | $391K | Buy |
9,575
+4,222
| +79% | +$172K | ﹤0.01% | 863 |
|
2022
Q2 | $295K | Buy |
+5,353
| New | +$295K | ﹤0.01% | 909 |
|